You are viewing a free limited preview of Horizon Therapeutics, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Horizon Therapeutics, Inc.

Private Company Ticker Symbol™: (HORTHEP)

Business Summary

Horizon Therapeutics, Inc. is a privately-held, venture capital backed biotechnology company that specializes in chronic pain management. Horizon Therapeutics, Inc. was founded in 2005 and is headquartered in Northbrook, Illinois.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2005
Fiscal Year End:12/31
City:Northbrook
State/Province:Illinois
Country:United States
Website:www.horizontherapeutics.com

Industry Information

Industry Codes

PICS™:700299
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Clinical Research Services > Other Clinical Research Services

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Horizon Therapeutics, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by Horizon Therapeutics, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
May. 2010ViewOtherVenture Capital
DetailsTotal Round Other View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on Horizon Therapeutics, Inc., you can see the following:

You are viewing a free limited preview of Horizon Therapeutics, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access